AgeX Therapeutics, Inc : AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Item 1.02 Termination of a Material Definitive Agreement. On November 27, 2023, Juvenescence Limited notified AgeX that Juvenescence is terminating a March 29, 20219 the.
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and nine months ended.
Merger to result in NYSE American-listed company focused on developing therapeutics based on Serina’s proprietary POZ Platform™ delivery technology
Lead program of the combined company will.
AgeX Therapeutics (AGE) and Serina Therapeutics to Merge streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.